Filing Details

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT 

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED 

PURSUANT TO RULE 13d-2

(Amendment No. 13)*

 

Select Medical Holdings Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

81619Q105

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

	¨	Rule 13d-1(b)
	¨	Rule 13d-1(c)
	x	Rule 13d-1(d)

 

 

^*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior coverage page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 81619Q105

 

1.	NAMES OF REPORTING PERSONS   Rocco A. Ortenzio
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) (b)	¨ ¨
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION   United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER	3,975,550
	6.	SHARED VOTING POWER	3,814,8051
	7.	SOLE DISPOSITIVE POWER	3,975,550
	8.	SHARED DISPOSITIVE POWER	3,814,8051

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   7,790,3551
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	¨
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9   6.07%1
12.	TYPE OF REPORTING PERSON IN

 

 

¹ Includes 10,000 shares of common stock owned by the reporting person’s spouse, as to which beneficial ownership is disclaimed.

 

 

Item 1(a).

Name of Issuer:

 

Select Medical Holdings Corporation

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

 

4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055

 

Item 2(a).

Name of Person Filing:

 

Rocco A. Ortenzio

 

Item 2(b).

Address of Principal Business Office or, if None, Residence:

 

c/o Select Medical Holdings Corporation 

4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055

 

Item 2(c).

Citizenship:

 

United States

 

Item 2(d).

Title of Class of Securities:

 

Common Stock, $.001 par value (“Common Stock”)

 

Item 2(e)

CUSIP Number:

 

81619Q105

 

Item 3.

If this Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: Not Applicable.

 

(a)

¨

Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

 

(b)

¨

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

 

(c)

¨

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

 

(d)

¨

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

 

(e)

¨

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

 

(f)

¨

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 

(g)

¨

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

(h)

¨

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)

¨

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

 

 

(j)

¨

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

 

(k)

¨

Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:_______________

 

Item 4.

Ownership.

 

The following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 is presented as of February 1, 2024:

  

(a)

Amount beneficially owned: 7,790,3551

 

(b)

Percent of class: 6.07%1 based upon 128,361,492 shares of Common Stock outstanding as of February 1, 2024.

 

(c)

Number of shares as to which such person has:

 

	(i)	Sole power to vote or to direct the vote
		3,975,550
	(ii)	Shared power to vote or to direct the vote
		3,814,8051
	(iii)	Sole power to dispose or to direct the disposition of
		3,975,550
	(iv)	Shared power to dispose or to direct the disposition of
		3,814,8051

  

Item 5.

Ownership of Five Percent or Less of a Class.

 

Not Applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not Applicable.

 

 

¹ Includes 10,000 shares of common stock owned by the reporting person’s spouse, as to which beneficial ownership is disclaimed.

 

 

Item 8.

Identification and Classification of Members of the Group.

 

Not Applicable.

 

Item 9.

Notice of Dissolution of Group.

 

Not Applicable.

 

Item 10.

Certifications.

 

Not applicable.

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	February 2, 2024
	Date
	/s/ Rocco A. Ortenzio
	Signature
	Rocco A. Ortenzio
	Name/Title